用LABA-ICS或LABA-LAMA治疗COPD的初始治疗:现实世界的比较有效性
Samy Suissa1,2, Mathew Cherian3, Sophie Dell'Aniello2
1Department of Epidemiology, Biostatistics and Medicine, McGill University, Montreal, Quebec, Canada samy.suissa@mcgill.ca.
BMJ open respiratory research
|December 19, 2025
概括
对于患有多次恶化的慢性阻塞性肺病 (COPD) 患者,使用长效β2激动剂和吸入性皮质类固醇 (LABA-ICS) 吸入器开始治疗可能比长效肌抗体 (LABA-LAMA) 吸入器更有效. 这项现实世界的研究表明了针对性治疗COPD的方法.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 现实世界的证据.
背景情况:
- 目前全球慢性阻塞性肺病倡议 (GOLD) 的指导方针建议LABA-LAMA用于多次恶化COPD患者的初始治疗.
- 这些建议是基于试验,这些试验排除了多次先前恶化的患者,质疑它们对这一特定人群的适用性.
- 作为初始疗法,LABA-ICS与LABA-LAMA的比较有效性,特别是在高恶化的COPD患者中,在现实环境中仍然不清楚.
研究的目的:
- 为了比较开始使用LABA-ICS与LABA-LAMA吸入器治疗COPD的实际有效性.
- 为了特别研究这种比较,在患有多次COPD恶化症的患者中进行比较.
- 评估在治疗开始后一年内中度或重度COPD恶化的发生率.
主要方法:
- 从英国临床实践研究数据链接中确定了一组超过37,000名成人COPD患者开始接受LABA-ICS或LABA-LAMA治疗.
- 这些患者曾经接受过喘,LABA,LAMA或ICS治疗.
- 倾向性评分权重被用于调整基线差异,并比较一年中中度或严重恶化的发病率.
主要成果:
- 与LABA-LAMA相比,启动LABA-ICS与类似的整体恶化风险有关 (调整HR 1.03).
- 然而,在患有两个或两个以上之前恶化的患者中,LABA-ICS显示恶化风险降低 (HR 0.89).
- 相反,LABA-ICS与没有先前恶化的患者的风险增加有关 (HR 1.07) 和预测FEV1≥50%的患者的风险降低 (HR 0.92).
结论:
- 开始使用LABA-ICS治疗COPD可能比LABA-LAMA在患有多次恶化的患者中更有效,特别是那些预测FEV1≥50%的患者.
- 在没有先前恶化和预测FEV1<50%的患者中,LABA-LAMA可能更有效.
- 这些发现支持个性化,有针对性的方法来选择COPD的初始药物治疗,基于恶化史和肺功能.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
700
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
700
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:23Inhaled Medications
687
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
687